Total Payments
$8,235
2023 Payments
$23.65
Companies
21
Transactions
203
Payment Breakdown by Category
Food & Beverage$4,317 (52.4%)
Consulting$2,830 (34.4%)
Travel$1,017 (12.4%)
Education$70.22 (0.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,317 | 196 | 52.4% |
| Consulting Fee | $2,830 | 1 | 34.4% |
| Travel and Lodging | $1,017 | 3 | 12.4% |
| Education | $70.22 | 3 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $5,258 | 69 | $0 (2022) |
| ViiV Healthcare Company | $771.72 | 34 | $0 (2023) |
| Janssen Biotech, Inc. | $599.38 | 41 | $0 (2019) |
| Galderma Laboratories, L.P. | $236.33 | 7 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $207.69 | 6 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $167.60 | 6 | $0 (2017) |
| EMD Serono, Inc. | $152.16 | 8 | $0 (2018) |
| Theratechnologies Inc. | $137.47 | 7 | $0 (2018) |
| Amarin Pharma Inc. | $135.20 | 2 | $0 (2017) |
| Aytu Bioscience, Inc | $119.22 | 4 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $23.65 | 1 | ViiV Healthcare Company ($23.65) |
| 2022 | $62.71 | 3 | ABBVIE INC. ($28.31) |
| 2021 | $51.85 | 3 | ViiV Healthcare Company ($37.13) |
| 2020 | $105.98 | 5 | Gilead Sciences, Inc. ($63.83) |
| 2019 | $503.25 | 28 | Janssen Biotech, Inc. ($130.53) |
| 2018 | $5,253 | 73 | Gilead Sciences, Inc. ($4,382) |
| 2017 | $2,234 | 90 | Gilead Sciences Inc ($652.42) |
All Payment Transactions
203 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/18/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: HIV | ||||||
| 11/01/2022 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $13.72 | General |
| 03/30/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $28.31 | General |
| Category: VIROLOGY | ||||||
| 02/23/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.68 | General |
| 08/18/2021 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: HIV | ||||||
| 04/28/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.72 | General |
| 03/03/2021 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: HIV | ||||||
| 11/13/2020 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: HIV | ||||||
| 10/31/2020 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.66 | General |
| 06/18/2020 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.42 | General |
| 03/11/2020 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.75 | General |
| 02/26/2020 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: HIV | ||||||
| 12/03/2019 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: HIV | ||||||
| 11/27/2019 | Merz North America, Inc. | XEOMIN (Biological), ASCLERA | Food and Beverage | Cash or cash equivalent | $18.60 | General |
| Category: DERMATOLOGY | ||||||
| 11/19/2019 | Janssen Biotech, Inc. | Symtuza (Drug), Juluca | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 11/13/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.85 | General |
| 11/05/2019 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: HIV | ||||||
| 10/30/2019 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $13.58 | General |
| 10/22/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.02 | General |
| 09/18/2019 | Janssen Biotech, Inc. | Symtuza (Drug), Juluca | Food and Beverage | In-kind items and services | $10.61 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 08/15/2019 | Janssen Biotech, Inc. | Symtuza (Drug), Juluca | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 08/13/2019 | Janssen Biotech, Inc. | Symtuza (Drug), Juluca | Food and Beverage | In-kind items and services | $4.37 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 08/08/2019 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $4.34 | General |
| 08/07/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.02 | General |
| 07/10/2019 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: HIV | ||||||
About Dr. Albert Canas, MD
Dr. Albert Canas, MD is a Internal Medicine healthcare provider based in Miami Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700967619.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Albert Canas, MD has received a total of $8,235 in payments from pharmaceutical and medical device companies, with $23.65 received in 2023. These payments were reported across 203 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($4,317).
Ad
Practice Information
- Specialty Internal Medicine
- Location Miami Beach, FL
- Active Since 10/18/2006
- Last Updated 02/07/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1700967619
Products in Payments
- Biktarvy (Drug) $1,193
- PREZCOBIX (Drug) $404.56
- JULUCA (Drug) $311.40
- TRIUMEQ (Drug) $294.03
- Symtuza (Drug) $283.04
- Truvada (Drug) $258.08
- BELSOMRA (Drug) $142.34
- Vascepa (Drug) $135.20
- SEROSTIM (Biological) $133.76
- DOVATO (Drug) $132.32
- EGRIFTA (Drug) $121.42
- Natesto (Drug) $119.22
- SHINGRIX (Biological) $57.68
- Mytesi (Drug) $56.54
- ISENTRESS (Drug) $48.04
- Androgel (Drug) $42.20
- REYATAZ (Drug) $37.82
- NASCOBAL (Drug) $37.57
- VIBERZI (Drug) $35.95
- MAVYRET (Drug) $28.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Miami Beach
Arin Newman, Md, MD
Internal Medicine — Payments: $705,556
Internal Medicine $705,556
Cynthia Rivera, M.d, M.D
Internal Medicine — Payments: $281,189
Internal Medicine $281,189
Dr. Simon Blanc, M.d, M.D
Internal Medicine — Payments: $119,116
Internal Medicine $119,116
Dr. Jason Shapiro, Md, MD
Internal Medicine — Payments: $69,524
Internal Medicine $69,524
Dr. Michael Wohlfeiler, Md, MD
Internal Medicine — Payments: $66,464
Internal Medicine $66,464
Dr. Christos Mihos, D.o, D.O
Internal Medicine — Payments: $61,438
Internal Medicine $61,438